Horne M K
Clinical Pathology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892.
Thromb Res. 1993 Apr 1;70(1):91-8. doi: 10.1016/0049-3848(93)90226-e.
Heparin is known to bind to activated platelets at two classes of sites. However, the true affinities of these sites for heparin have been uncertain because the measurements have been made in the presence of heparin-binding proteins secreted by the platelets. Of these proteins platelet factor-4 (PF4) has the greatest affinity for heparin and is present in relatively high concentrations. Furthermore, a portion of the secreted PF4 binds to the platelet surface. Nevertheless, by gel-filtering platelets in the presence of 5 micrograms/ml heparin, we prepared platelets that were virtually free of PF4. The high and low affinities of these cells for heparin were respectively ten- and two-fold greater than the apparent affinities measured in the presence of the secreted platelet proteins. In contrast, neither the high- nor the low-affinity heparin binding capacity of these cells was altered, indicating that PF4, even though it binds to both heparin and platelets, appears not to link heparin to platelets.
已知肝素可在两类位点与活化血小板结合。然而,由于这些位点对肝素的真实亲和力是在血小板分泌的肝素结合蛋白存在的情况下进行测量的,所以一直不确定。在这些蛋白中,血小板因子4(PF4)对肝素的亲和力最大,且浓度相对较高。此外,一部分分泌的PF4会结合到血小板表面。尽管如此,通过在5微克/毫升肝素存在的情况下对血小板进行凝胶过滤,我们制备出了几乎不含PF4的血小板。这些细胞对肝素的高亲和力和低亲和力分别比在分泌的血小板蛋白存在时测得的表观亲和力大10倍和2倍。相比之下,这些细胞的高亲和力和低亲和力肝素结合能力均未改变,这表明PF4尽管能与肝素和血小板都结合,但似乎并未将肝素与血小板连接起来。